Ramos A, González M, López-Hoyos M, Carrió R, Merino J
Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Immunology. 1996 Nov;89(3):413-8. doi: 10.1046/j.1365-2567.1996.d01-763.x.
The injection of spleen cells from F1 mice into-newborns from a parental strain results in the establishment of cytolytic tolerance to donor alloantigens and the development of a lupus-like disease. This syndrome is the consequence of the recognition by alloreactive host CD4+ T cells of discordant major histocompatibility complex (MHC) class II antigens on semi-allogeneic donor B cells. We have analysed whether completely allogeneic spleen cells are as able as semi-allogeneic spleen cells to induce cytolytic tolerance to donor alloantigens and to co-operate with alloreactive T cells for autoantibody production. BALB/c mice were injected at birth with Thy-1-depleted spleen cells from (C57BL/6 x BALB/c)F1 or C57BL/6 mice, either alone or in combination. Cytolytic tolerance was always induced, as manifested by persistence of chimerism and acceptance of skin allografts. However, only F1 semi-allogeneic B cells were activated by alloreactive host T cells to produce anti-DNA IgG antibody. The deficient co-operation between BALB/c CD4+ T cells and completely allogeneic C57BL/6 B cells was confirmed after neonatal injection of (C57BL/ 6 x BALB/c)F1(Igha) spleen cells together with C57BL/6(Ighb) spleen cells. These mice developed anti-DNA antibodies bearing only the Igha allotype. Similar results were observed in experiments of allogeneic interaction in vitro, in which BALB/c CD4+ T cells were cocultured with either (C57BL/6 x BALB/c)F1 or C57BL/6 B cells. The present results demonstrate that completely allogeneic spleen cells efficiently induced cytolytic unresponsiveness to donor alloantigens, but B cells contained in this spleen cell population were unable to establish allo-helper interactions with alloreactive CD4+ T cells, suggesting that cytolytic and helper T-cell interactions involved in alloreactivity may be different.
将F1小鼠的脾细胞注射到亲本品系的新生小鼠体内,会导致对供体同种异体抗原建立溶细胞耐受性,并引发类似狼疮的疾病。这种综合征是同种反应性宿主CD4 + T细胞识别半同种异体供体B细胞上不一致的主要组织相容性复合体(MHC)II类抗原的结果。我们分析了完全同种异体脾细胞是否与半同种异体脾细胞一样,能够诱导对供体同种异体抗原的溶细胞耐受性,并与同种反应性T细胞协同产生自身抗体。新生BALB/c小鼠单独或联合注射来自(C57BL/6×BALB/c)F1或C57BL/6小鼠的去除Thy-1的脾细胞。溶细胞耐受性总是会被诱导,表现为嵌合体的持续存在和皮肤同种异体移植的接受。然而,只有F1半同种异体B细胞被同种反应性宿主T细胞激活以产生抗DNA IgG抗体。在新生小鼠注射(C57BL/6×BALB/c)F1(Igha)脾细胞和C57BL/6(Ighb)脾细胞后,证实了BALB/c CD4 + T细胞与完全同种异体的C57BL/6 B细胞之间的合作不足。这些小鼠产生了仅带有Igha同种异型的抗DNA抗体。在体外同种异体相互作用实验中也观察到了类似结果,其中BALB/c CD4 + T细胞与(C57BL/6×BALB/c)F1或C57BL/6 B细胞共培养。目前的结果表明,完全同种异体脾细胞能有效地诱导对供体同种异体抗原的溶细胞无反应性,但该脾细胞群体中所含的B细胞无法与同种反应性CD4 + T细胞建立同种辅助相互作用,这表明同种反应性中涉及的溶细胞和辅助性T细胞相互作用可能不同。